Lysosome Enlargement Enhanced Photochemotherapy Using a Multifunctional Nanogel
Source abstract
Abstract
Large lysosomes are susceptible toward rupture because of an increased membrane tension. Here we report a strategy to first enlarge and weaken the lysosome and then destroy it to boost the efficiency of photochemotherapy using a hyaluronan nanogel, carrying chloroquine as a lysosomal expander, rhodamine B as a photosensitive lysosomal destroyer, and cisplatin as a chemotherapeutic. This all-in-one nanogel provides a facile approach and new insight into improve the photochemotherapy, by making use of lysosome's size, as a risk factor in lysosomal destabilization.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Photodynamic Therapy Research Studies · Retinopathy of Prematurity Studies · Neonatal Health and Biochemistry
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Molecular Imaging Innovations Institute, Department of Radiology, Weill Cornell Medicine, New York, New York 10065, United States
Funding
National Institute of General Medical Sciences
References (29)
Show source-provided references
1. 10.1038/nbt.333010.1038/nbt.3330 ↗
2. 10.1039/C0CS00003E10.1039/C0CS00003E ↗
3. 10.1016/j.jconrel.2010.11.00410.1016/j.jconrel.2010.11.004 ↗
4. 10.3390/ph511117710.3390/ph5111177 ↗
5. 10.1016/j.drup.2015.11.00410.1016/j.drup.2015.11.004 ↗
6. 10.1021/acschembio.7b0023710.1021/acschembio.7b00237 ↗
7. 10.1021/nn400704810.1021/nn4007048 ↗
8. 10.1038/onc.2008.31010.1038/onc.2008.310 ↗
9. 10.1016/j.ejphar.2009.06.06310.1016/j.ejphar.2009.06.063 ↗
10. 10.1021/jm060736s10.1021/jm060736s ↗
11. 10.1016/j.biomaterials.2013.09.10210.1016/j.biomaterials.2013.09.102 ↗
12. 10.1124/jpet.104.06608410.1124/jpet.104.066084 ↗
13. 10.1016/j.taap.2011.12.00410.1016/j.taap.2011.12.004 ↗
14. 10.1128/MCB.23.2.665-676.200310.1128/MCB.23.2.665-676.2003 ↗
15. 10.1039/c2sm25538c10.1039/c2sm25538c ↗
16. 10.1002/advs.20160010610.1002/advs.201600106 ↗
17. 10.1038/ncomms462310.1038/ncomms4623 ↗
18. Berg K. · Cancer Res. · 1999 · 59 · 1180
19. 10.1021/acsami.6b1650010.1021/acsami.6b16500 ↗
20. 10.1039/C6CC08230K10.1039/C6CC08230K ↗
21. 10.1016/j.biomaterials.2011.06.07710.1016/j.biomaterials.2011.06.077 ↗
22. 10.1093/annonc/mdn39510.1093/annonc/mdn395 ↗
23. 10.1124/jpet.110.17567910.1124/jpet.110.175679 ↗
24. 10.1158/0008-5472.CAN-06-044810.1158/0008-5472.CAN-06-0448 ↗
25. 10.1002/cmdc.20060005310.1002/cmdc.200600053 ↗
26. 10.1142/S108842460300020310.1142/S1088424603000203 ↗
27. 10.1111/j.1751-1097.1991.tb03669.x10.1111/j.1751-1097.1991.tb03669.x ↗
28. 10.1186/1759-2208-2-410.1186/1759-2208-2-4 ↗
29. 10.1038/nnano.2010.27710.1038/nnano.2010.277 ↗